Dr. Roy M. Joseph, MD

Dr. Joseph practices at Texas Digestive Disease Consultants in Denton, Texas.

Dr. Joseph's NPI, 1205864667, was assigned on June 28, 2006. Dr. Joseph graduated from St. John's Medical College in 1986. Dr. Joseph holds Texas license K3266.

Dr. Joseph's primary practice is Texas Digestive Disease Consultants, at 3324 Colorado Blvd, Denton, TX 76210 in Denton County. The practice phone is (972) 691-3777.

Dr. Joseph's primary practice is Texas Digestive Disease Consultants in Denton, Texas. Dr. Joseph is also affiliated with Medical City Denton. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Joseph to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joseph practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Joseph's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Joseph is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Joseph is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis and gastroenteritis among the conditions Dr. Joseph treats.

CMS data shows 595 Medicare services from Dr. Joseph across 9 procedure codes in 2024, for 255 Medicare patients. Medicare paid $60,856 for them.

CMS counts 255 Medicare patients who saw Dr. Joseph in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Joseph's median patient age at 59, with 49% women.

In 2024, Dr. Joseph wrote 1,013 Medicare Part D claims for 327 patients. 74% of them were for generic drugs. CMS names the drug for 835 of them, across 14 drugs with 11 or more claims each, at $181,377 in total drug cost. In 2023, CMS named 684 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Joseph for performance year 2024, reported as part of a group. Dr. Joseph accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Joseph as offering telehealth. CMS counts 66 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Joseph, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 22 papers to Dr. Joseph, published from 2012 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Biocompatible Materials, Alginates and Gelatin. Dr. Joseph has published most often in J Biomed Mater Res A.

CMS Open Payments shows 39 general payments to Dr. Joseph from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $236.

Dmand AI lists 1 award for Dr. Joseph.

Dr. Joseph graduated from St. John's Medical College in 1986. Dr. Joseph is a member of ACG.

Dr. Joseph is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.